| abstract |
The invention relates to oxoazaheterocyclyl compounds that inhibit Factor Xa, oxoazaheterocyclyl compounds that inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method to directly inhibit Factor Xa and a method to directly and simultaneously inhibit Factor Xa and Factor IIa. |